Highlights from the 71st Annual American College of Rheumatology - A Continuing Education Series
Welcome to the The 71st Annual American College of Rheumatology Meeting Highlights: a Continuing Education Series, an integrated educational series that will allow rheumatologists and related healthcare professionals to access a variety of media and tools developed specifically to highlight key data from the 2007 ACR meeting and incorporate it into various formats and media. The series will provide information on the latest research on the use of biologics and other novel therapies in the management of rheumatic diseases as discussed at the 71st Annual ACR Meeting held in Boston, MA.
After successful completion of this activity, participants should be able to:
- Discuss important new findings presented at the annual 2007 ACR meeting.
- Assess how biologics and other novel therapies can be incorporated into appropriate rheumatic disease management strategies based on their different mechanisms of actions, response rates, frequency of administrations and safety and tolerability profiles.
- Recognize the long-term implications of these therapies on joint preservation, cardiovascular complications and other risk factors.
The following enduring materials are available in such formats as:
- ConferenceCast Summaries (HTML / PDF)
- Podcast: Bluesky Audio Recording Series
- PDA: Skyscape CMEStat
- ACR Toolkit
Please refer to each program’s link to access the activities.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturers of any commercial products discussed in this program. The presenting faculty reported the following:
- Alan Baer, MD has no financial relationships to disclose.
- Jon T. Giles, MD discloses receiving Grants and/or Research Support from Roche and Centocor; Honoraria from Prous Science and Amgen and serving as a consultant for Abbott Laboratories
- Vicky Ruffing, MD discloses that she serves as a consultant for Roche, Amgen, Genentech, BMS and Abbott.
This initiative is presented by The Johns Hopkins University School of Medicine; and is in collaboration with the Rheumatology Nurses Society (RNS). This activity is made possible by an unrestricted educational grant from Amgen and is managed by Gullapalli and Associates, LLC.
